Byeong Hwa Jeon Selected Research

Byeong Hwa Jeon Research Topics

Disease

20	Inflammation (Inflammations) 01/2024 - 07/2011
13	Neoplasms (Cancer) 01/2024 - 05/2008
7	Atherosclerosis 06/2021 - 06/2011
7	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2014
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 06/2011
4	Hypertension (High Blood Pressure) 01/2018 - 07/2013
3	Ischemia 05/2023 - 11/2015
3	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2011
3	Urinary Bladder Neoplasms (Bladder Cancer) 05/2016 - 10/2015
3	Lung Neoplasms (Lung Cancer) 12/2013 - 05/2008
2	Cardiotoxicity 01/2024 - 04/2012
2	Non-alcoholic Fatty Liver Disease 01/2022 - 06/2021
2	Seizures (Absence Seizure) 07/2020 - 01/2020
2	Chronic Disease (Chronic Diseases) 03/2018 - 12/2013
2	Neoplasm Metastasis (Metastasis) 01/2018 - 08/2010
2	Neointima 01/2018 - 01/2009
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2017 - 09/2015
2	Aortic Coarctation 09/2015 - 07/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2012 - 05/2008
2	Carcinogenesis 02/2012 - 12/2011
2	Adenocarcinoma of Lung 06/2010 - 05/2008
2	Sepsis (Septicemia) 03/2009 - 07/2006
1	Cardiomyopathies (Cardiomyopathy) 01/2024
1	Wounds and Injuries (Trauma) 05/2023
1	Cicatrix (Scar) 12/2021
1	Keloid 12/2021
1	Fatty Liver 06/2021
1	Body Weight (Weight, Body) 06/2021
1	Thrombosis (Thrombus) 01/2021
1	Atherosclerotic Plaque (Atheroma) 09/2020
1	Vascular Calcification 09/2017
1	Chronic Renal Insufficiency 09/2017
1	Brain Diseases (Brain Disorder) 12/2016
1	Spinal Cord Injuries (Spinal Cord Injury) 08/2016

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2024 - 07/2008
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 12/2013
7	EndonucleasesIBA 01/2024 - 02/2012
5	Biomarkers (Surrogate Marker)IBA 03/2020 - 02/2012
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2021 - 05/2009
3	salicylhydroxamic acid (SHAM)IBA 05/2023 - 07/2008
3	ApolipoproteinsIBA 06/2021 - 03/2018
3	LipopolysaccharidesIBA 01/2019 - 05/2009
3	ArginaseIBA 01/2018 - 06/2011
3	DNA (Deoxyribonucleic Acid)IBA 12/2017 - 09/2015
3	Superoxides (Superoxide)IBA 01/2009 - 05/2008
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2023 - 05/2008
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 07/2013
2	Sirtuin 1IBA 01/2021 - 01/2018
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2021 - 07/2017
2	Apolipoproteins E (ApoE)IBA 09/2020 - 03/2018
2	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 08/2015
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 11/2016
2	Angiotensin IIIBA 01/2018 - 03/2015
2	CytokinesIBA 01/2018 - 05/2013
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018 - 12/2015
2	EndotoxinsIBA 12/2016 - 03/2007
2	Neuroprotective AgentsIBA 08/2016 - 11/2015
2	HexanesIBA 09/2014 - 12/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2013 - 06/2010
2	AntioxidantsIBA 02/2013 - 05/2008
1	AnthracyclinesIBA 01/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024
1	sericiteIBA 01/2022
1	CollagenIBA 12/2021
1	capsanthinIBA 06/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 06/2021
1	PowdersIBA 06/2021
1	Alanine (L-Alanine)FDA Link 06/2021
1	LipidsIBA 06/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	SRT1720IBA 01/2021
1	SolutionsIBA 01/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2021
1	CenobamateIBA 07/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2018
1	Anthocyanins (Anthocyanin)IBA 03/2018
1	FlavonoidsIBA 03/2018
1	Polo-Like Kinase 1IBA 01/2018
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	Troponin IIBA 12/2017
1	Phosphates (Orthophosphate)IBA 09/2017
1	TEMPOIBA 07/2017
1	PhytochemicalsIBA 05/2017
1	NeurotoxinsIBA 12/2016
1	Tryptophan (L-Tryptophan)FDA Link 08/2016
1	Histidine (L-Histidine)FDA Link 08/2016
1	Bretschneider cardioplegic solutionIBA 08/2016
1	Type I Tumor Necrosis Factor ReceptorsIBA 03/2016
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2016
1	Sulfhydryl Compounds (Thiols)IBA 03/2016

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 10/2015 - 12/2009
1	Oral Administration 06/2021
1	Intraperitoneal Injections 01/2021
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2020
1	Therapeutics 01/2018